Status:
COMPLETED
Anosmia and Covid-19
Lead Sponsor:
University College, London
Conditions:
Anosmia
SARS CoV 2 Infection
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Our study aims to determine the prevalence of anosmia in patients SARS-Cov-2/Covid-19 infection (both by symptom reporting and smell testing), the efficacy of early olfactory training for the treatmen...
Detailed Description
Around 10-15% of patients with acquired anosmia have Post Viral Olfactory Loss (PVOL). Coronaviruses are a known cause for anosmia. At the onset of the COVID-19 pandemic, reports from China, South Kor...
Eligibility Criteria
Inclusion
- Confirmed (positive laboratory antigen test) or suspected COVID-19 infection
- Sudden onset of smell loss
- Smell loss of at least 4 weeks
- Reduced smell function through psycho-physical testing (Brief Smell Identification Test score of 8 or less)
Exclusion
- \-
Key Trial Info
Start Date :
June 3 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 8 2021
Estimated Enrollment :
63 Patients enrolled
Trial Details
Trial ID
NCT05246059
Start Date
June 3 2020
End Date
August 8 2021
Last Update
February 18 2022
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Barts Health NHS Foundation Trust
London, England, United Kingdom
2
Guy's and St. Thomas' NHS Foundation Trust
London, England, United Kingdom
3
Wrightington, Wigan and Leigh NHS Foundation Trust
Wigan, England, United Kingdom
4
James Paget and Norfolk & Norwich University Hospitals
Gorleston-on-Sea, Great Yarmouth, United Kingdom